{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:18:52Z","timestamp":1777558732010,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To estimate the effect of catheter ablation combined with left appendage occlusion in the treatment of non-valvular atrial fibrillation (NVAF) by a method of meta-analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Pubmed, Embase, and Cochrane Library were searched for the studies about catheter ablation combined with left appendage occlusion in treating NVAF. The data analysis was performed using R\u00a04.0.5\u00a0software. The retrieval time was from inception to May 12, 2021.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 18 published studies were identified in the meta-analysis, including 1385 participants. During the perioperative period of catheter ablation combined with left appendage occlusion in treating NVAF, the pooled incidences of pericardial effusion, major or minor bleeding events, and residual flow documented were 0.5%(95%CI 0.0002\u20130.0099), 1.42%(95% CI 0.00\u20130.04), 7.24%(95% CI 0.0447\u20130.0975), respectively. During the follow-up, the incidences of all-cause mortality, embolism events, and bleeding events were 0.32%(95%CI 0.0000\u20130.0071), 1.29%(95%CI 0.0037\u20130.0222), 2.07%(95% CI 0.0075\u20130.0339), respectively. In the follow-up period of the transesophageal echocardiography, the most complication was residual flow event with an incident rate of 10.80%(95% CI 0.054\u20130.1620). The maximum occurrence probability of residual flow events was 17.92% (95% CI 0.1133\u20130.2452). Moreover, the incident rate of NVAF recurrence was 29.23% (95% CI 0.2222\u20130.3623).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The meta-analysis suggests that the \u201cone-stop\u201d procedure is effective for those patients undergoing NVAF. However, Patients with more residual blood flow have a higher incidence of bleeding complications. More studies are warranted to verify the safety and efficacy of catheter ablation combined with left appendage occlusion in terms of the \u201cone-stop\u201d procedure.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-022-01885-9","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T13:06:20Z","timestamp":1654002380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of catheter ablation combined with left appendage occlusion for non-valvular atrial fibrillation: a meta-analysis"],"prefix":"10.1186","volume":"17","author":[{"given":"Jun","family":"Qu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"issue":"2","key":"1885_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3909\/ricm0733","volume":"15","author":"MJ Price","year":"2014","unstructured":"Price MJ. Left atrial appendage occlusion with the WATCHMAN\u2122 for stroke prevention in atrial fibrillation. Rev Cardiovasc Med. 2014;15(2):142\u201351.","journal-title":"Rev Cardiovasc Med"},{"issue":"1","key":"1885_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/CIRCEP.109.859116","volume":"3","author":"R Cappato","year":"2010","unstructured":"Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32\u20138.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"21","key":"1885_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"64","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, et al. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1-76.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1885_CR4","first-page":"50","volume":"70","author":"P Kirchhof","year":"2017","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Rev Esp Cardiol (Engl Ed). 2017;70(1):50.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"1","key":"1885_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","volume":"64","author":"DR Holmes Jr","year":"2014","unstructured":"Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1\u201312.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"1885_CR6","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","volume":"70","author":"VY Reddy","year":"2017","unstructured":"Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017;70(24):2964\u201375.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"1885_CR7","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/europace\/euv070","volume":"17","author":"N Calvo","year":"2015","unstructured":"Calvo N, Salterain N, Arguedas H, Macias A, Esteban A, Garc\u00eda de Y\u00e9benes M, et al. Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation. Europace. 2015;17(10):1533\u201340.","journal-title":"Europace"},{"issue":"6","key":"1885_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jacep.2015.07.009","volume":"1","author":"A Alipour","year":"2015","unstructured":"Alipour A, Swaans MJ, van Dijk VF, Balt JC, Post MC, Bosschaert MAR, et al. Ablation for atrial fibrillation combined with left atrial appendage closure. JACC Clin Electrophysiol. 2015;1(6):486\u201395.","journal-title":"JACC Clin Electrophysiol"},{"issue":"2","key":"1885_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.joa.2015.11.001","volume":"32","author":"KP Phillips","year":"2016","unstructured":"Phillips KP, Walker DT, Humphries JA. Combined catheter ablation for atrial fibrillation and Watchman\u00ae left atrial appendage occlusion procedures: five-year experience. J Arrhythm. 2016;32(2):119\u201326.","journal-title":"J Arrhythm"},{"issue":"11","key":"1885_CR10","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/europace\/euw007","volume":"18","author":"G Fassini","year":"2016","unstructured":"Fassini G, Conti S, Moltrasio M, Maltagliati A, Tundo F, Riva S, Dello Russo A, Casella M, Majocchi B, Zucchetti M, et al. Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation. Europace. 2016;18(11):1705\u201310.","journal-title":"Europace"},{"issue":"7","key":"1885_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097.","journal-title":"PLoS Med"},{"issue":"9","key":"1885_CR12","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","volume":"73","author":"K Slim","year":"2003","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Chipponi J. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712\u20136.","journal-title":"ANZ J Surg"},{"issue":"11","key":"1885_CR13","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/europace\/euy025","volume":"20","author":"L Wintgens","year":"2018","unstructured":"Wintgens L, Romanov A, Phillips K, Ballesteros G, Swaans M, Folkeringa R, et al. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry. Europace. 2018;20(11):1783\u20139.","journal-title":"Europace"},{"issue":"5","key":"1885_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.002212","volume":"1","author":"MJ Swaans","year":"2012","unstructured":"Swaans MJ, Post MC, Rensing BJ, Boersma LV. Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study. J Am Heart Assoc. 2012;1(5): e002212.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"1885_CR15","first-page":"687","volume":"5","author":"DT Walker","year":"2012","unstructured":"Walker DT, Humphries JA, Phillips KP. Combined catheter ablation for atrial fibrillation and Watchman(\u00ae) left atrial appendage occlusion procedures: a single centre experience. J Atr Fibrillation. 2012;5(3):687.","journal-title":"J Atr Fibrillation"},{"key":"1885_CR16","volume":"72","author":"MJ Swaans","year":"2013","unstructured":"Swaans MJ, Alipour A, Rensing BJ, Post MC, Boersma LV. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation. J Vis Exp. 2013;72: e3818.","journal-title":"J Vis Exp"},{"issue":"1","key":"1885_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10840-015-0030-4","volume":"44","author":"A Romanov","year":"2015","unstructured":"Romanov A, Pokushalov E, Artemenko S, Yakubov A, Stenin I, Kretov E, et al. Does left atrial appendage closure improve the success of pulmonary vein isolation? Results of a randomized clinical trial. J Interv Card Electrophysiol. 2015;44(1):9\u201316.","journal-title":"J Interv Card Electrophysiol"},{"key":"1885_CR18","doi-asserted-by":"crossref","unstructured":"Panikker S, Jarman JW, Virmani R, Kutys R, Haldar S, Lim E, et al. Left atrial appendage electrical isolation and concomitant device occlusion to treat persistent atrial fibrillation: a first-in-human safety, feasibility, and efficacy study. Circ Arrhythm Electrophysiol. 2016;9(7).","DOI":"10.1161\/CIRCEP.115.003710"},{"issue":"12 Suppl 1","key":"1885_CR19","first-page":"11s","volume":"18","author":"E Pelissero","year":"2017","unstructured":"Pelissero E, Giuggia M, Todaro MC, Trapani G, Giordano B, Senatore G. Combined left atrial appendage percutaneous closure and atrial fibrillation ablation: a single center experience. G Ital Cardiol (Rome). 2017;18(12 Suppl 1):11s\u20137s.","journal-title":"G Ital Cardiol (Rome)"},{"issue":"6","key":"1885_CR20","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/europace\/eux183","volume":"20","author":"KP Phillips","year":"2018","unstructured":"Phillips KP, Pokushalov E, Romanov A, Artemenko S, Folkeringa RJ, Szili-Torok T, et al. Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up. Europace. 2018;20(6):949\u201355.","journal-title":"Europace"},{"issue":"8","key":"1885_CR21","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/jce.13631","volume":"29","author":"X Du","year":"2018","unstructured":"Du X, Chu H, He B, Wang B, Liu J, Feng M, et al. Optimal combination strategy of left atrial appendage closure plus catheter ablation in a single procedure in patients with nonvalvular atrial fibrillation. J Cardiovasc Electrophysiol. 2018;29(8):1089\u201395.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"11","key":"1885_CR22","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/pace.14084","volume":"43","author":"XX Li","year":"2020","unstructured":"Li XX, Tian Y, Shi L, Wang YJ, Zeng LJ, Huang LH, et al. One-stop hybrid procedure combining catheter ablation and left atrial appendage closure increases long-term risk for adverse events in patients with atrial fibrillation. PACE. 2020;43(11):1358\u201365.","journal-title":"PACE"},{"key":"1885_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.610537","volume":"7","author":"Z Ren","year":"2020","unstructured":"Ren Z, Zhang J, Wang S, Jia P, Li X, Zhang J, et al. Two-year outcome from combining cryoballoon ablation and left atrial appendage closure: CLACBAC study. Front Cardiovasc Med. 2020;7: 610537.","journal-title":"Front Cardiovasc Med"},{"key":"1885_CR24","doi-asserted-by":"publisher","first-page":"8615410","DOI":"10.1155\/2020\/8615410","volume":"2020","author":"BF Mo","year":"2020","unstructured":"Mo BF, Sun J, Zhang PP, Li W, Chen M, Yuan JL, et al. Combined therapy of catheter ablation and left atrial appendage closure for patients with atrial fibrillation: a case-control study. J Interv Cardiol. 2020;2020:8615410.","journal-title":"J Interv Cardiol"},{"issue":"12","key":"1885_CR25","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1097\/CM9.0000000000000855","volume":"133","author":"M Chen","year":"2020","unstructured":"Chen M, Wang ZQ, Wang QS, Sun J, Zhang PP, Feng XF, et al. One-stop strategy for treatment of atrial fibrillation: feasibility and safety of combining catheter ablation and left atrial appendage closure in a single procedure. Chin Med J (Engl). 2020;133(12):1422\u20138.","journal-title":"Chin Med J (Engl)"},{"key":"1885_CR26","first-page":"6573296","volume":"2020","author":"Z Ren","year":"2020","unstructured":"Ren Z, Zhang J, Zhu M, Zhao D, Li S, Yang H, et al. Cryoablation combined with left atrial appendage closure: a safe and effective procedure for paroxysmal atrial fibrillation patients. Cardiol Res Pract. 2020;2020:6573296.","journal-title":"Cardiol Res Pract"},{"issue":"10","key":"1885_CR27","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","volume":"27","author":"HJ Lin","year":"1996","unstructured":"Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, et al. Stroke severity in atrial fibrillation. Framingham Study Stroke. 1996;27(10):1760\u20134.","journal-title":"Framingham Study Stroke"},{"issue":"9689","key":"1885_CR28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534\u201342.","journal-title":"Lancet"},{"issue":"1","key":"1885_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/pace.13845","volume":"43","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Li F, Li D, Cheng Y, Jia Y, Fu H, et al. Efficacy and safety of catheter ablation combined with left atrial appendage occlusion for nonvalvular atrial fibrillation: a systematic review and meta-analysis. PACE. 2020;43(1):123\u201332.","journal-title":"PACE"},{"key":"1885_CR30","doi-asserted-by":"crossref","unstructured":"Garcia-Villarreal OA. Surgical closure of the left atrial appendage basal considerations before attempting with occluder devices. J Surg. 2017;3(2).","DOI":"10.16966\/2470-0991.144"},{"issue":"2","key":"1885_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.joa.2014.08.005","volume":"31","author":"SM Singh","year":"2015","unstructured":"Singh SM, Jimenez-Juan L, Danon A, Bastarrika G, Shmatukha AV, Wright GA, et al. Magnetic resonance imaging of the left atrial appendage post pulmonary vein isolation: Implications for percutaneous left atrial appendage occlusion. J Arrhythm. 2015;31(2):108\u201313.","journal-title":"J Arrhythm"},{"issue":"14","key":"1885_CR32","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","volume":"71","author":"L Fauchier","year":"2018","unstructured":"Fauchier L, Cinaud A, Brigadeau F, Lepillier A, Pierre B, Abbey S, et al. Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol. 2018;71(14):1528\u201336.","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01885-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-022-01885-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01885-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T13:16:44Z","timestamp":1654003004000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-022-01885-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1885"],"URL":"https:\/\/doi.org\/10.1186\/s13019-022-01885-9","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"assertion":[{"value":"28 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not needed because this is a meta-analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}